Morgan Stanley’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.4K | Buy |
2,164
+852
| +65% | +$7.63K | ﹤0.01% | 6659 |
|
|
2025
Q1 | $8.29K | Sell |
1,312
-3,018
| -70% | -$19.1K | ﹤0.01% | 6856 |
|
|
2024
Q4 | $44.7K | Sell |
4,330
-8,718
| -67% | -$90K | ﹤0.01% | 6320 |
|
|
2024
Q3 | $168K | Sell |
13,048
-3,187
| -20% | -$41K | ﹤0.01% | 5815 |
|
|
2024
Q2 | $225K | Buy |
16,235
+14,947
| +1,160% | +$207K | ﹤0.01% | 5610 |
|
|
2024
Q1 | $401K | Buy |
+1,288
| New | +$401K | ﹤0.01% | 5410 |
|
|
2023
Q3 | – | Sell |
-10
| Closed | -$2.1K | – | 7672 |
|
|
2023
Q2 | $2.1K | Buy |
+10
| New | +$2.1K | ﹤0.01% | 7184 |
|
|
2023
Q1 | – | Hold |
0
| – | -$3 | – | 7788 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7847 |
|
|
2022
Q2 | – | Sell |
-162
| Closed | -$33K | – | 7900 |
|
|
2022
Q1 | $33K | Sell |
162
-27
| -14% | -$5.5K | ﹤0.01% | 6901 |
|
|
2021
Q4 | $41K | Sell |
189
-414
| -69% | -$89.8K | ﹤0.01% | 6908 |
|
|
2021
Q3 | $275K | Sell |
603
-1,105
| -65% | -$504K | ﹤0.01% | 5830 |
|
|
2021
Q2 | $685K | Sell |
1,708
-436
| -20% | -$175K | ﹤0.01% | 5320 |
|
|
2021
Q1 | $1.24M | Buy |
2,144
+1,860
| +655% | +$1.08M | ﹤0.01% | 4593 |
|
|
2020
Q4 | $162K | Buy |
284
+270
| +1,929% | +$154K | ﹤0.01% | 5693 |
|
|
2020
Q3 | $8K | Sell |
14
-18
| -56% | -$10.3K | ﹤0.01% | 6333 |
|
|
2020
Q2 | $18K | Buy |
+32
| New | +$18K | ﹤0.01% | 6033 |
|